Display options
Share it on

Exp Hematol Oncol. 2014 Jun 04;3:15. doi: 10.1186/2162-3619-3-15. eCollection 2014.

Salvage therapy with high dose Intravenous Immunoglobulins in acquired Von Willebrand Syndrome and unresponsive severe intestinal bleeding.

Experimental hematology & oncology

Massimo Cugno, Alberto Tedeschi, Simona Maria Siboni, Francesca Stufano, Federica Depetri, Franca Franchi, Samantha Griffini, Flora Peyvandi

Affiliations

  1. Department of Pathophysiology and Transplantation, University of Milan, Milano, Italy ; Medicina Interna, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
  2. Unità Operativa di Allergologia e Immunologia Clinica, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy.
  3. Department of Pathophysiology and Transplantation, University of Milan, Milano, Italy ; Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, and Luigi Villa Foundation, Milan, Italy.
  4. Department of Pathophysiology and Transplantation, University of Milan, Milano, Italy ; Medicina Interna, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milano, Italy ; Angelo Bianchi Bonomi Haemophilia and Thrombosis Centre, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, and Luigi Villa Foundation, Milan, Italy.

PMID: 24926417 PMCID: PMC4055248 DOI: 10.1186/2162-3619-3-15

Abstract

A 91-year-old woman affected with acquired Von Willebrand (VW) syndrome and intestinal angiodysplasias presented with severe gastrointestinal bleeding (hemoglobin 5 g/dl). Despite replacement therapy with VW factor/factor VIII concentrate qid, bleeding did not stop (eleven packed red blood cell units were transfused over three days). High circulating levels of anti-VW factor immunoglobulin M were documented immunoenzimatically. Heart ultrasound showed abnormalities of the mitral and aortic valves with severe flow alterations. When intravenous immunoglobulins were added to therapy, prompt clinical and laboratory responses occurred: complete cessation of bleeding, raise in hemoglobin, VW factor antigen, VW ristocetin cofactor and factor VIII levels as well as progressive reduction of the anti-VWF autoantibody levels.

Keywords: Acquired von Willebrand syndrome; Gastrointestinal bleeding; Intravenous immunoglobulin

References

  1. Autoimmun Rev. 2012 Sep;11(11):792-4 - PubMed
  2. Am J Hematol. 2006 Aug;81(8):616-23 - PubMed
  3. Nat Rev Immunol. 2013 Mar;13(3):176-89 - PubMed
  4. Am J Obstet Gynecol. 2005 Jun;192(6):2067-70 - PubMed
  5. Blood. 1998 Oct 15;92(8):2707-11 - PubMed
  6. Haemophilia. 2005 Nov;11(6):633-7 - PubMed
  7. Genet Med. 2011 May;13(5):365-76 - PubMed
  8. Eur J Immunol. 2012 Dec;42(12):3302-9 - PubMed
  9. Thromb Res. 2012 Dec;130 Suppl 2:S2-6 - PubMed
  10. Haemophilia. 2010 Jul;16 Suppl 5:67-73 - PubMed
  11. Autoimmun Rev. 2013 Apr;12(6):639-42 - PubMed
  12. J Thromb Haemost. 2006 Oct;4(10):2103-14 - PubMed
  13. N Engl J Med. 2012 Nov 22;367(21):2015-25 - PubMed
  14. Transfus Med Rev. 2007 Apr;21(2 Suppl 1):S9-56 - PubMed
  15. Autoimmun Rev. 2014 Jan;13(1):40-8 - PubMed
  16. Blood. 1968 Jun;31(6):806-12 - PubMed
  17. Semin Thromb Hemost. 2013 Mar;39(2):191-201 - PubMed
  18. BMC Med. 2013 Apr 04;11:89 - PubMed
  19. Blood. 2013 Nov 28;122(23):3735-40 - PubMed
  20. Blood. 2011 Jun 23;117(25):6777-85 - PubMed
  21. Transfusion. 2013 Aug;53(8):1730-5 - PubMed
  22. Am J Hematol. 2007 Jan;82(1):55-8 - PubMed
  23. Blood. 1994 Apr 15;83(8):2171-9 - PubMed
  24. J Thromb Haemost. 2008 Apr;6(4):565-8 - PubMed
  25. Semin Thromb Hemost. 2011 Feb;37(1):35-40 - PubMed
  26. Blood. 2009 May 21;113(21):5049-57 - PubMed
  27. Haemophilia. 2013 Jul;19(4):e256-7 - PubMed
  28. Haematologica. 2013 May;98(5):667-74 - PubMed

Publication Types